<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Summary of the pharmacological properties of 
   <italic>Thymus vulgaris</italic> L.
  </p>
 </caption>
 <alt-text id="alttext0045">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Pharmacological Activity</th>
    <th>Type of Study</th>
    <th>Models used</th>
    <th>Plant part/material</th>
    <th>Type of extract/compound</th>
    <th>Doses used</th>
    <th>Controls</th>
    <th>Possible/reported mechanisms</th>
    <th>Results</th>
    <th>References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="7">Antibacterial activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Escherichia coli, Klebsiella pneumoniae, Yersinia enterocolitica, Staphylococcus aureus, Listeria monocytogenes, Enterococcus faecalis</italic>
    </td>
    <td>Aerial parts</td>
    <td>Ethanol</td>
    <td>100 μl of 6.25–0.025% serial dilutions</td>
    <td>Solvent ethanol</td>
    <td>Not defined</td>
    <td>MIC was observed as &gt;6.25, 3.12,&gt;6.25, 0.2, 0.39, 0.78 mm respectively at 100 μl concentration (p &lt; 0.05). These bacteria showed mixed response towards antibiotics.</td>
    <td>[
     <xref rid="bib53" ref-type="bibr">53</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Methicillin-resistant 
     <italic>Staphylococcus aureus</italic> (MRSA) in mice
    </td>
    <td>Not defined</td>
    <td>Methanol</td>
    <td>200 mg/ml per kg of body weight</td>
    <td>Positive control-infected, negative control-normal mice, Antibiotics</td>
    <td>Not defined</td>
    <td>For the bacteria isolated from throat and lungs, MIC was found to be 2.93 and 3.83 CFU (log
     <sub>10</sub>)/ml, respectively (p &lt; 0.05).
    </td>
    <td>[
     <xref rid="bib54" ref-type="bibr">54</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Salmonella typhirium</italic>
    </td>
    <td>Aerial parts</td>
    <td>Essential oil</td>
    <td>100 μl of 1/20–1/200 v/v serial dilutions</td>
    <td>Amoxicillin, cefotaxime</td>
    <td>Not defined</td>
    <td>MIC of 25.5 mm at 100 μl concentration, in accordance with amoxicillin (23.0 mm) and cefotaxime (15.0 mm) (p &lt; 0.05).</td>
    <td>[
     <xref rid="bib55" ref-type="bibr">55</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Salmonella</italic> Enteritidis Biofilm
    </td>
    <td>Dried plant</td>
    <td>Essential oil</td>
    <td>5–0.0024 μl/ml.</td>
    <td>Growth control (broth + microbe), negative control (broth + propylene glycol + microbe), sterility control (broth + test oil), positive control (broth + streptomycin + microbe)</td>
    <td>Possible inhibition of bacterial adsorption and biofilm matrix formation</td>
    <td>Biofilm inhibition at MIC/MBC 0.156/0.315 μl/ml by oil, thymol, and carvacrol. Oil reduced the metabolic activity by 9.6–70.5%, (p &lt; 0.05).</td>
    <td>[
     <xref rid="bib13" ref-type="bibr">13</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Staphylococcus aureus</italic> (MDR)
    </td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>10 μl of 2.87–11.5 μg/ml</td>
    <td>Cefotaxime</td>
    <td>Not defined</td>
    <td>A significant inhibition with 35–40 mm inhibition zone at 2.8–11.5 at μg/ml was observed for MDR variants, whereas cefotaxime showed MIC at 32 μg/mL concentration (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib11" ref-type="bibr">11</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Pseudomonas aeruginosa</italic>
    </td>
    <td>Leaves and branches</td>
    <td>Essential oil</td>
    <td>100 μl oil of different concentrations</td>
    <td>Not defined</td>
    <td>Not defined</td>
    <td>Minimum bactericidal concentration (MBC) was found to be 8% at 100 μl concentration</td>
    <td>[
     <xref rid="bib56" ref-type="bibr">56</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Actinobacillus pleuropneumoniae, Streptococcus suis, Actinobacillussuis, Haemophilus parasuis, Pasteurella multocida, and Bordetella bronchiseptica</italic>
    </td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>100 μl of 1.25 to 0.01% (v/v)</td>
    <td>Media + microbes + PBS</td>
    <td>Not defined</td>
    <td>MIC values ranging from 0.039% to 0.078% at dilutions 0.01–1.25% v/v (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib57" ref-type="bibr">57</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="5">Antioxidant activity</td>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Antioxidant enzyme levels in rabbits</td>
    <td>Not defined</td>
    <td>Aqueous extract</td>
    <td>50 mg/kg of body weight</td>
    <td>Water</td>
    <td>Not defined</td>
    <td>Levels of antioxidant enzymes catalase, glutathione, glutathione-S-transferase, and superoxide dismutase increased by 14.12%, 27.69%, 98.75% and 78.29%, respectively (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib58" ref-type="bibr">58</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Antioxidant enzyme levels in rats</td>
    <td>Dried leaves</td>
    <td>Aqueous extract</td>
    <td>500 mg/kg body weight</td>
    <td>Paracetamol (200 mg/kg)</td>
    <td>Not defined</td>
    <td>Alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase content increased by 2 units/mL. In combination with paracetamol, the enzyme levels increased by 15–20 units/ml (p &lt; 0.01)</td>
    <td>[
     <xref rid="bib59" ref-type="bibr">59</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Radical scavenging activity using DPPH</td>
    <td>Leaf and stem</td>
    <td>Aqueous extract</td>
    <td>0.0125–3.0 mg/ml</td>
    <td>Not defined</td>
    <td>Polysaccharide biding with BSA brings out the radical scavenging</td>
    <td>Radical free scavenging activity of 92.0% at the concentration of 1.5 mg/mL, in accordance with butylated hydroxyanisole (BHA-95.7%) and butylated hydroxytoluene (BHT-96.6%).</td>
    <td>[
     <xref rid="bib52" ref-type="bibr">52</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>FRAP, ABTS, and FIC</td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>0.23–30 mg/ml</td>
    <td>Not defined</td>
    <td>Not defined</td>
    <td>FRAP, FIC, ABTS assays showed IC
     <sub>50</sub> values 12.69, 13.29, and 6.46 mg/ml respectively (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib60" ref-type="bibr">60</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Primary and secondary lipid oxidation products in oil in water (O/W) emulsions through DPPH</td>
    <td>Dry waste plant</td>
    <td>Ethanolic extract</td>
    <td>100 μl of different concentrations</td>
    <td>Not defined</td>
    <td>Not defined</td>
    <td>IC
     <sub>50</sub> of 93 μg/ml compared to BHT (89 μg/mL) (p &gt; 0.05)
    </td>
    <td>[
     <xref rid="bib61" ref-type="bibr">61</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="5">Antifungal activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Sclerotinia sclerotiorum</italic>, 
     <italic>Botrytis cinerea</italic>, 
     <italic>Phytophthora parasitica</italic>, 
     <italic>Pythium aphanidermatum</italic>, 
     <italic>Fusarium oxysporum</italic>, 
     <italic>Alternaria brassicae</italic>, 
     <italic>Trichoderma aggressivum</italic>f.sp. 
     <italic>europaeum</italic>, 
     <italic>Cladobotryum mycophilum</italic>
    </td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>5,10,15,20,30% (v/v)</td>
    <td>Media + Tween 20</td>
    <td>Not defined</td>
    <td>Mycelial growth inhibition values were found to be ranging between 13.9 to 41.4 mm at 5% concentration with ED
     <sub>50</sub> values ranging from 9.3-18.0% for all the species (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib14" ref-type="bibr">14</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Clinical isolates of 
     <italic>Candida albicans</italic> and 
     <italic>C. glabrata</italic> species
    </td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>0.005–2.5% (v/v)</td>
    <td>Amphotericin B</td>
    <td>Possible ergosterol binding</td>
    <td>MIC and MFC were in the range of 0.04–22.9 mg/ml for all the isolates. Thyme oil reduced the fungal growth in the initial hours (4–8). It inhibited the growth with sorbitol at lower MIC (0.08 mg/ml) (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib15" ref-type="bibr">15</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>
     <italic>C. albicans</italic> in a 
     <italic>Caenorhabditis elegans</italic> nematode model
    </td>
    <td>Not defined</td>
    <td>Thymol</td>
    <td>32, 64, and 128 mg/l</td>
    <td>Kanamycin (45 μg/ml), ampicillin (100 μg/mL), and streptomycin (100 μg/ml)</td>
    <td>Enhancing pmk-1and sec-1 gene expressions, which in turn enhance p38 MAPK signalling pathway</td>
    <td>Complete inhibition of fungi and biofilm at 64 mg/l and 128 mg/ml, compared to control used (p &lt; 0.05). Growth reduction at 12 h, compared to control (36 h). Thymol enhances the expressions of pmk-1and sec-1 genes, in turn p38 MAPK signalling pathway</td>
    <td>[
     <xref rid="bib62" ref-type="bibr">62</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Cryptococcus neoformans</italic>
    </td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>0.07–10 mg/ml</td>
    <td>FLC (0.06–128 μg/mL), ITC (0.0078–2 μg/ml), VRC (0.0078–32 μg/mL)</td>
    <td>Possible membrane deterioration by thymol, Possible ergosterol binding</td>
    <td>MIC and MFC were found to be in 0.56–1.12 mg/ml in accordance with controls. Thymol showed better activity 0.02–0.08 mg/ml (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib63" ref-type="bibr">63</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>
     <italic>Aspergillus flavus</italic>
    </td>
    <td>Not defined</td>
    <td>Essential oil vapour and liquid phases</td>
    <td>0, 1, 5, 10, and 20 μg/ml</td>
    <td>Aflatoxin B</td>
    <td>Downregulating of fungal development genes brlA, abaA, wetA and aflatoxin biosynthesis genes aflR, aflD, and aflK</td>
    <td>Vapor and liquid phases reduced growth at 20 and 400 μg/ml, respectively. Thyme oil 10 μg/mL of reduced production of afltoxin by 97.0 and 56.4% through vapour and liquid phases, respectively. (p &lt; 0.05).</td>
    <td>[
     <xref rid="bib16" ref-type="bibr">16</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="4">Anti-inflammatory activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>NO radical scavenging in murine macrophage cell line J774A.1</td>
    <td>Flowering tops</td>
    <td>Aqueous extract</td>
    <td>8.5, 16, 50.4, 84 μg/ml</td>
    <td>Dexamethasone</td>
    <td>Possible cellular mechanisms of suppression of iNOS induction by flavonoids</td>
    <td>Significant scavenging of NO radicals with 80.3% of the activity at 16 μg/ml concentration was observed in accordance with control (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib19" ref-type="bibr">19</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>5-lipoxygenease (5-LOX) production, lipopolysaccharide (LPS) induced TNF-α, IL-1β, and IL-8 secretions using THP-1 cells</td>
    <td>Dried plant</td>
    <td>Essential oil</td>
    <td>30 μl of different concentrations</td>
    <td>α-bisabolol</td>
    <td>Not defined</td>
    <td>5-LOX got inhibited at 0.005 μg/ml (IC
     <sub>50</sub>) of thyme oil, compared to α-bisabolol (0.049 μg/mL). TNF-α, IL-1β, and IL-8 got inhibited at 0.01 μg/ml.
    </td>
    <td>[
     <xref rid="bib20" ref-type="bibr">20</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Mice with carrageenan-induced paw edema</td>
    <td>Aerial parts and dried leaves</td>
    <td>Essential oil</td>
    <td>100, 200 and 400 mg/kg</td>
    <td>Tween 80 and diclofenac</td>
    <td>Not defined</td>
    <td>Paw thickness was found reducing at a dose of 400 mg/kg. Results were in accordance with both the controls Tween 80 and diclofenac (p &lt; 0.001). Toxic level of thyme oil was found (4500 mg/kg), where sedation was observed at 5000 mg/kg.</td>
    <td>[
     <xref rid="bib43" ref-type="bibr">43</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Mice with carrageenan-induced pleurisy</td>
    <td>Leaves</td>
    <td>Essential oil</td>
    <td>250, 500 and 750 mg/kg</td>
    <td>Croton oil</td>
    <td>Carvacrol may act by inhibiting cytokines and leukotrienes, and these mediators are likely not involved in the mechanism of action of thymol</td>
    <td>All the concentrations reduced inflammatory exudates as well as migrated leucocytes in ear edema. Individual assessment showed thymol (34.2%) and carvacrol (47.3%) are attributable for the anti-inflammatory activity (p &lt; 0.05)</td>
    <td>[
     <xref rid="bib64" ref-type="bibr">64</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="6">Anti-cancerous activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>MCF7 (breast adenocarcinoma), HCT15 (colon carcinoma), HeLa (cervical carcinoma), HepG2 (hepatocellular carcinoma), and NCI-H460 (non-small cell lung cancer) cell lines</td>
    <td>Dried aerial parts</td>
    <td>Essential oil</td>
    <td>10–100 μg/ml</td>
    <td>Ellipticine (0.24–65.2 μg/ml)</td>
    <td>Possible involvement of thymol in the stimulation of active proliferation of pulp fibroblasts</td>
    <td>
     <italic>T. vulgaris</italic> L. oil showed inhibition of growth at 76.02–180.40 μg/ml concentration (GI
     <sub>50</sub>). It did not show any effect on non-tumour liver PLP cells, even at a high concentration of 400 μg/ml (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib65" ref-type="bibr">65</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>THP-1 leukemia cell line</td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>10–500 μg/ml</td>
    <td>DMSO</td>
    <td>Not defined</td>
    <td>At a concentration of 100 μg/ml and &gt;200 μg/ml, thyme oil prevented the proliferation of THP-1 leukemia cells</td>
    <td>[
     <xref rid="bib66" ref-type="bibr">66</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>H460 lung cancer cell line</td>
    <td>Not defined</td>
    <td>Hydroalcoholic extract</td>
    <td>0.04–0.6%</td>
    <td>Glyceraldehyde 3-phosphate dehydrogenase</td>
    <td>Possible interference in pro-inflammatory cytokines</td>
    <td>H460 lung cancer cell line was found to be sensitive at 0.11% of hydroalcoholic extract (p &lt; 0.05) and downregulated NF-κB p65 and NF-κB p52 proteins along with the reduction of IL-1β and IL-8 gene expression in LPS model</td>
    <td>[
     <xref rid="bib21" ref-type="bibr">21</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Mammary carcinoma rat and 4T1 mouse models</td>
    <td>Dried plant</td>
    <td>Thyme powder</td>
    <td>50 mg/kg body weight</td>
    <td>Untreated models</td>
    <td>Possible interference with pro-inflammatory cytokines, Possible upregulation of caspase genes at epigenetic level</td>
    <td>Thyme powder reduced the volume of 4T1 tumours by 85% at 1% concentration. In rat model, the same concentration decreased the tumour frequency by 53% (p &lt; 0.05). Upregulation of caspase-2 and caspase-3 enzymes, along with bcl-2 and Bax proteins</td>
    <td>[
     <xref rid="bib67" ref-type="bibr">67</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>HL-60 acute promyelotic leukemia cell line, human peripheral blood mononuclear cell (PBMC)</td>
    <td>Not defined</td>
    <td>Thymol</td>
    <td>5, 25, 50, 75 and 100 μM for 24 h</td>
    <td>Camptothecin (5 μM)</td>
    <td>Apoptosis induced by thymol in HL-60 cells was associated with ROS production, increase in mitochondrial H
     <sub>2</sub>O
     <sub>2</sub> production, decrease in Bcl-2 protein, increase in Bax protein levels, enhancing apoptosis inducing factor (AIF) in mitochondria and caspase activation
    </td>
    <td>Thymol showed no cytotoxic effect on human peripheral blood mononuclear cell (PBMC) at 5 and 25μM concentrations. However, extensive cytotoxicity was observed at &gt;50 μM, after 24 h</td>
    <td>[
     <xref rid="bib68" ref-type="bibr">68</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Synthesized silver nanoparticles against T47D human breast cancer cells</td>
    <td>Dried leaves</td>
    <td>Silver nanoparticles and ethanol extract</td>
    <td>12.5–200 μg/ml</td>
    <td>Untreated cells</td>
    <td>Nanoparticles could trig- ger translocation of phosphatidylserine (PS) from the inner membrane indicating apoptosis pathway rather than necrosis</td>
    <td>T47D cells showed high sensitivity towards nanoparticles (90%) compared to the extract (75%). T47D cells treated with nanoparticles showed 18.40% early and 0.69% late apoptosis with varying IC
     <sub>50</sub> concentrations (12.5–100 μg/mL). Same was observed in case of plant extract, where 15.67% early and 1.70% late apoptosis was found (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib47" ref-type="bibr">47</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="4">Antiviral activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Influenza virus</td>
    <td>Not defined</td>
    <td>Essential oil vapour and liquid phases</td>
    <td>3.12–100 μl/ml</td>
    <td>Canova oil</td>
    <td>Possible interaction with hemagglutinin (HA)</td>
    <td>Liquid phase at 3.1 μl/ml concentration completely inhibited the viral growth, which was better than that of control used (canola oil). Significant inhibition of HA was observed. Also, 50% of the culture was reduced depicted as TC
     <sub>50</sub> 14.34 μl/ml (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib33" ref-type="bibr">33</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Herpes simplex virus (HSV) on RC-37 (African green monkey kidney cells)</td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>10–750 μg/ml</td>
    <td>Untreated cells</td>
    <td>Not defined</td>
    <td>Cytotoxicity ranged between 20 μg/ml for citral and 1250 μg/ml for 1,8-cineole. IC
     <sub>50</sub> values for1,8-cineole was 1200 μg/ml. Thyme oil proved to reduce the viral load by &gt;96%, whereas all monoterpenes by &gt;80% (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib69" ref-type="bibr">69</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>HIV-1 in HeLa HL3T1 cell line</td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>7.5–240
     <break/>μg/ml
    </td>
    <td>Neomycin, cisplatin</td>
    <td>Possible alteration in the structure of Tat/TAR-RNA complex</td>
    <td>EMSA showed a notable inhibitory potential of oil (3–6 μg/ml), compared to the control in case of Tat/TAR-RNA complex inhibition. Reduction activity test against Tat-induced HIV-1 LTR transcription resulted in RT
     <sub>50</sub> = 0,83 μg/ml, a notable inhibitory potential which reduced viral transcription to 52% (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib70" ref-type="bibr">70</xref>]
    </td>
   </tr>
   <tr>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>HIV-1 subtype A in PBMC cell line</td>
    <td>Dried plant</td>
    <td>Methanol extract</td>
    <td>10, 100, 200, 800 and 1600 μg/ml</td>
    <td>DMSO, Zidovudine</td>
    <td>Not defined</td>
    <td>The cytotoxicity value (CC
     <sub>50</sub>) on PBMC was found to be 200 μg/ml. Antiviral assay revealed EC
     <sub>50</sub> value of &gt;500 μg/ml. Mean fluorescent intensity (MFI) of the CD4+ expressions were found to be 22.72 in PBMC (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib71" ref-type="bibr">71</xref>]
    </td>
   </tr>
   <tr>
    <td>Antidiabetic activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Inhibition of α-glucosidase and α-amylase enzymes</td>
    <td>Not defined</td>
    <td>Aqueous, methanol and ethanol extracts</td>
    <td>4, 8, 15, and 20 μg/ml</td>
    <td>Acarbose</td>
    <td>Not defined</td>
    <td>Methanol extract resulted in maximum inhibition of α-glucosidase (IC
     <sub>50</sub> 4.35, 22.04, 30.77, 43.13), though less compared to Acarbose (IC
     <sub>50</sub> 16.11, 44.6, 53.03, 63.70). Similarly, α-amylase got reduced maximally by the same extract (IC
     <sub>50</sub> 6.39, 11.47, 17.01, 22.93), less compared to Acarbose (IC
     <sub>50</sub> 12.37, 25.16, 36.08, 44.97)
    </td>
    <td>[
     <xref rid="bib72" ref-type="bibr">72</xref>]
    </td>
   </tr>
   <tr>
    <td>Anxiolytic activity</td>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Elevated plus-maze (EPM) rat model</td>
    <td>Dried plant</td>
    <td>Aqueous extract</td>
    <td>50 mg/kg, 100 mg/kg, and 200 mg/kg</td>
    <td>Saline fed groups</td>
    <td>Possible relation with antioxidant activity of phytochemicals</td>
    <td>The aqueous extract exhibited a significant increase in rat movement into the open arms at 100 mg/kg (p &lt; 0.05) and 200 mg/kg (p &lt; 0.01).</td>
    <td>[
     <xref rid="bib74" ref-type="bibr">74</xref>]
    </td>
   </tr>
   <tr>
    <td>UV-protective activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Human skin cells</td>
    <td>Not defined</td>
    <td>Aqueous extract, thymol</td>
    <td>1.82 μg/ml extract and 1 μg/ml thymol</td>
    <td>Normal cells without UV treatment, but with extract treatment</td>
    <td>Reduction of ROS induced DNA damage, Possible involvement of polyphenols in protectivity</td>
    <td>Aqueous extract of thyme leaf (1.82 μg/ml) and thymol (1 μg/ml) reduced the release lactic acid dehydrogenase (LDH), in cultured skin cells treated with UV rays. Cell proliferation was observed in thyme pre-treated skin cells in accordance with control, along with the reduction in DNA damage (p &lt; 0.01)</td>
    <td>[
     <xref rid="bib75" ref-type="bibr">75</xref>]
    </td>
   </tr>
   <tr>
    <td>Anthelminthic activity</td>
    <td>
     <italic>in vitro</italic>
    </td>
    <td>Eimeria spp. oocysts from Turkey fowls</td>
    <td>Not defined</td>
    <td>Essential oil</td>
    <td>0, 1, 2, 4, 8, 10, 20, 40, 80, and 800 mg/ml</td>
    <td>Ammonia and diclazuril</td>
    <td>Not defined</td>
    <td>Thyme oil showed significant anti-helminthic activity against 4 species of 
     <italic>Eimeria</italic> spp. at IC
     <sub>50</sub> 53.42 mg/ml for 5×10
     <sup>4</sup> oocysts (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib40" ref-type="bibr">40</xref>]
    </td>
   </tr>
   <tr>
    <td>Anti-anti-alzheimer's activity</td>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Acetylcholine esterase and nicotinic acetylcholine receptor in 
     <italic>C. elegans</italic> nematode model
    </td>
    <td>Aerial parts and leaves</td>
    <td>Essential oil</td>
    <td>10, 20, 40, 60, 80, and 100 ppm</td>
    <td>10% DMSO</td>
    <td>Upregulation of unc-17, unc-50, and cho-1 genes by ρ-Cymene</td>
    <td>Enhancement of the nicotinic acetylcholine receptor activity, upregulation of unc-17, unc-50, and cho-1 genes at 40 and 60 ppm ρ-Cymene was attributed for gene upregulation activity along with downregulating ace-1 and ace-2 at 20 and 100 ppm (p &lt; 0.05). Thymol and γ-terpinene enhanced synaptic acetylcholine levels in combination (40 ppm)</td>
    <td>[
     <xref rid="bib76" ref-type="bibr">76</xref>]
    </td>
   </tr>
   <tr>
    <td>Anti-osteoporotic activity</td>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Rat model with low calcium intake</td>
    <td>Dried leaves</td>
    <td>Leaf powder</td>
    <td>5% w/w</td>
    <td>Standard diet + normal calcium (Ca 0.5% w/w), standard diet + low calcium (Ca 0.1% w/w), Thyme powder (5% w/w) + low calcium (Ca 0.1% w/w)</td>
    <td>Possible promotion of calcium resorption in the gut</td>
    <td>Significant increase in the bone mass (2.93 g/kg), length 32.8 mm), and density (0.13 g/cm
     <sup>2</sup>), compared to low calcium diet control (2.46 g/kg, 32.2 mm, and 0.09 g/cm
     <sup>2</sup>, respectively) (p &lt; 0.05)
    </td>
    <td>[
     <xref rid="bib77" ref-type="bibr">77</xref>]
    </td>
   </tr>
   <tr>
    <td>Anti-pulpotomy activity</td>
    <td>
     <italic>in vivo</italic>
    </td>
    <td>Formocresolpulpotomy in humans</td>
    <td>Not defined</td>
    <td>Ethanolic extract</td>
    <td>Suitable consistency</td>
    <td>Formocresol</td>
    <td>Not defined</td>
    <td>Thyme ethanolic extract along with zinc oxide reduced pain and tenderness, Enhanced bone and root resorption. Clinical and radiographic evaluations showed 94.4% and 88.2% success, respectively with no statistical significance compared to the control, formocresol 88.2% (p &gt; 0.05)</td>
    <td>[
     <xref rid="bib78" ref-type="bibr">78</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
